ArticleInternational journal of molecular sciences2025

Dual Inhibition of SRC Family Kinases and Sorafenib Enhances Anti-Tumor Activity in Hepatocellular Carcinoma Cells.

Loraine Kay Cabral et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.